Cargando…
The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19
Early in the COVID-19 pandemic, anecdotal reports emerged suggesting non-steroidal anti-inflammatory drugs (NSAIDs) may increase susceptibility to infection and adversely impact clinical outcomes. This narrative literature review (March 2020–July 2021) attempted to clarify the relationship between N...
Autores principales: | Kushner, Pamela, McCarberg, Bill H., Grange, Laurent, Kolosov, Anton, Haveric, Anela Lihic, Zucal, Vincent, Petruschke, Richard, Bissonnette, Stephane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489480/ https://www.ncbi.nlm.nih.gov/pubmed/36127354 http://dx.doi.org/10.1038/s41533-022-00300-z |
Ejemplares similares
-
Tramadol extended-release in the management of chronic pain
por: McCarberg, Bill
Publicado: (2007) -
Topical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injury
por: McCarberg, B H, et al.
Publicado: (2010) -
Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Gastroprotective NSAIDs on the Gastrointestinal Tract: A Narrative Review
por: Sohail, Rohab, et al.
Publicado: (2023) -
Crystal structure of the non-steroidal anti-inflammatory drug (NSAID) tolmetin sodium
por: Konovalova, Irina S., et al.
Publicado: (2021) -
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
por: Bindu, Samik, et al.
Publicado: (2020)